Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic.

Tatar, Erhan; Erdi, Zuleyha Can; Ozgur, Oyku; Tasdemir, Anil; Tatar, Bengu

Tatar, Erhan; Erdi, Zuleyha Can; Ozgur, Oyku; Tasdemir, Anil; Tatar, Bengu.

Tatar E; Division of Nephrology, Izmir Bozyaka Education and Research Hospital, University of Health Sciences, 9035170, Karabaglar, Izmir, Turkey. etatar@hotmail.com.
Erdi ZC; Department of Internal Medicine, Izmir Bozyaka Education and Research Hospital, University of Health Sciences, Izmir, Turkey.
Ozgur O; Department of Internal Medicine, Izmir Bozyaka Education and Research Hospital, University of Health Sciences, Izmir, Turkey.
Tasdemir A; Department of Internal Medicine, Izmir Bozyaka Education and Research Hospital, University of Health Sciences, Izmir, Turkey.
Tatar B; Department of Infectious Diseases and Clinical Microbiology, Izmir Tepecik Training and Research Hospital, University of Health Sciences, Izmir, Turkey.

Int Urol Nephrol ; 54(2): 459-460, 2022 Feb.

Article in English | MEDLINE | ID: covidwho-1384546

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Atypical Hemolytic Uremic Syndrome/drug therapy; COVID-19/epidemiology; Pandemics; SARS-CoV-2; Adult; Atypical Hemolytic Uremic Syndrome/epidemiology; Complement Inactivating Agents/therapeutic use; Female; Humans; Recurrence

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / Antibodies, Monoclonal, Humanized / Atypical Hemolytic Uremic Syndrome / SARS-CoV-2 / COVID-19 Type of study: Case report / Observational study Limits: Adult / Female / Humans Language: English Journal: Int Urol Nephrol Year: 2022 Document Type: Article Affiliation country: S11255-021-02890-Y

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google